Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced ...

J.P. Morgan analyst Doug Anmuth said he sees room for Alphabet, Google’s parent, to gain ground on a variety of fronts, ...

Carvana fell again Friday a day after short-seller Hindenburg Research criticized the used-car retailer in an extensive ...

J.P. Morgan Asset Management’s Michael Cembalest calls them “Alchemists” — the Trump White House nominees who are looking to ...

The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...

In Ultragaz, the company has been strengthening its presence in the bulk market with associated solutions and better margins, ...

Then, next week, Nvidia is on the road again at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, which ...

J.P. Morgan Chase, with about 300,000 employees worldwide, is expected to announce the end of hybrid and remote work in the ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the 43rd Annual J.P.

In a report released today, Ryan Brinkman from J.P. Morgan maintained a Sell rating on Tesla (TSLA – Research Report), with a price target of ...

M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...